IPOPEMA Securities S.A (IPE) Fair Value & Analysis
Financial Services · PL · Market cap 219M PLN
Fair value as of: Jul 16, 2026
From 13 valuation models · updated 25 days ago
Share price +24.3% over the past month.
A solid business, but screening 31% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (7.93 PLN). The favourable scenario is already priced in.
- Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range 1.44 PLN – 9.20 PLN · fair‑value band 4.76 PLN – 7.93 PLN · the 9.20 PLN price screens above the 6.34 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.
Analysis
IPOPEMA Securities S.A (IPE) currently trades at 9.20 PLN, while our model-based Fair Value estimate is 6.34 PLN, implying the stock looks roughly 31.1% overvalued today. The Quality Score stands at 64/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, IPOPEMA Securities S.A generated revenue of 269M PLN at a net margin of 3.4%. Revenue grew 21.6% year over year. It earns a return on equity of 8.3%. The balance sheet holds a net cash position of 171M PLN. Fundamentals as of Jul 16, 2026
Our scenario range runs from 4.76 PLN (bear case) to 7.93 PLN (bull case); at 9.20 PLN, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 258% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 11% fair-value upside, at -31%, IPE screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: DCF Models (17.66 PLN) versus Dividend Discount (2.31 PLN). Highest evidence: Growth DCF (80).
Notify me when IPE reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 92
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
IPOPEMA Securities S.A., together with its subsidiaries, provides brokerage, company analysis, and investment banking services in Poland.
Full company description
IPOPEMA Securities S.A., together with its subsidiaries, provides brokerage, company analysis, and investment banking services in Poland. The company engages in the brokerage and investment banking activities; distribution of investment products; and provision of investment advisory services to a range of individual investors, as well as advisory services related to corporate financial restructuring and financing for infrastructure projects. It also involves in the creation and management of investment funds; management of portfolios of brokerage financial instruments; business and management consulting; information technology facilities management; information technology consulting; and software-related activities. In addition, the company offers investment banking services, including preparation and execution of capital market transactions, public issues of securities, mergers and acquisitions (M&A) transactions, management buyouts, and advisory services for raising private market financing, as well as organizing buyback transactions for shares listed on the Warsaw Stock Exchange through public tender offers and buy-back programs. Further, it provides portfolio management services; securities trading advisory services; intermediation services; involved in the creation and management of closed-end and open-end investment funds; and wholesale of computers, peripherals, and software. IPOPEMA Securities S.A. was incorporated in 2005 and is based in Warsaw, Poland.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
IPOPEMA Securities S.A reported revenue of 297M PLN in FY2025 versus 256M PLN in FY2021, a compound +3.7%/yr. Reported net income was 23.9M PLN in FY2025, compounding +16.2%/yr from FY2021.
of which total revenue +13.1 pp · buybacks/dilution +0.0 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
IPE screens 31% overvalued. Compare with Huatai Securities Co →
Peer Group
Capital Markets · 423 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Capital Markets median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Capital Markets stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Huatai Securities Co HTSC | $0.2700 | $0.0400 | -85% |
| Mirae Asset Securities Co 006800 | 38,750 KRW | 31,645 KRW | -18% |
| Meritz Financial Group 138040 | 117,000 KRW | 87,706 KRW | -25% |
| Korea Investment Holdings 071050 | 239,000 KRW | 318,825 KRW | +33% |
| NH Investment & Securities Co 005940 | 31,000 KRW | 37,133 KRW | +20% |
| Samsung Securities Co 016360 | 107,700 KRW | 126,487 KRW | +17% |
| Motilal Oswal Financial Services Limited MOTILALOFS | ₹967.00 | ₹299.65 | -69% |
| Kiwoom Securities Co 039490 | 322,000 KRW | 358,091 KRW | +11% |
| SSI Securities Corporation SSI | 24,250 VND | 28,021 VND | +16% |
| Bolsas y Mercados Argentinos S.A BYMA | 313.75 ARS | 120.22 ARS | -62% |
Compare IPOPEMA Securities S.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is IPOPEMA Securities S.A (IPE) overvalued or undervalued?
What is the fair value of IPE?
What is the quality score of IPE?
What is the revenue of IPOPEMA Securities S.A (IPE)?
What is the net profit margin of IPE?
Does IPOPEMA Securities S.A pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track IPOPEMA Securities S.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.